News

The study results, published in The New England Journal of Medicine (NEJM Vol. 362 No. 25), also demonstrated cost savings in use of the fractional-dose intradermal injection as

The multiplex testing applications include tests for infectious diseases, cancer, companion diagnostics, autoimmune disease, genetic screening, and pharmacogenomics. The Applied BioCode’s BMB integrate the semiconductor’s photolithographic technology with

As per the terms of the agreement, AIM is expected to provide Health Evaluations; Immunizations; Ergonomic Education, Assessments and Programs; Health Education, Promotion and Training; and Workplace Investigations.

The successful inspection comes following Axxess Pharma’s most recent letter of intent (LOI) to acquire a Canada-based pharmaceutical manufacturer. Axxess Pharma’s facility is roughly 22,000sqft and manufactures pharmaceuticals,

Nymox said that compared to baseline, symptoms of urgency to urinate reduced by 52% at 90 days after a single treatment with NX-1207, and the improvement was positive

XP13512 is a patented new chemical entity discovered by XenoPort. GSK and XenoPort said that the failure of the study may be a consequence of the unexpectedly high

invivodata’s ePRO solutions, DiaryPRO and SitePRO, which are used for field-based data collection and for in-clinic based data collection are expected to provide complementary functionality to Total Clinical

As per the contract, Selvita is expected to take up responsibility for early research on the program and for the discovery and early preclinical development of small molecules,

The lawsuit was filed as a result of an abbreviated new drug application (ANDA) filed by Zydus seeking FDA approval to market and sell generic versions of Lialda